administered. It's almost a year long with about a dozen returns throughout. It's a double-blind placebo, but all participants will get the drug at the end of the trial. I will DM you the rest for confidentiality.

With this first phase of the study, they have pretty strict requirements. They said the next phase (hopefully in a few years) will be less strict. I was a bit mistaken, it is an RNA therapy, but not mRNA. I don't recall which type it is. For myself, I'm going back up in two weeks to get the drug

I will DM you the info for enrollment! As long as they are able to walk unaided and have no high-risk health factors (e.g., morbid obesity), they are probably eligible. I know both of those disqualify because my BMI was on the border 😬, and my sister and dad couldn't get in due to mobility.

Thank you!

Hank, let me tell you about one amazing opportunity coming from mRNA research. Spinocerebellar ataxia type 2 (SCA2) runs in my family. THIS WEEK my dad and sister and I are traveling to McGill University in Canada to get screened for an mRNA trial that could potentially cure the disease!